ascopubs.org

Multiomic factor analysis for pathologic complete response (pCR) after 12 weeks of pembrolizumab + trastuzumab + pertuzumab in HER2-enriched (HER2-E) early breast cancer (eBC ...

Prediction of pCR with pretreatment MRI radiomics in triple negative breast cancer treated with neoadjuvant chemo-immunotherapy. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I.
Pensions&Investments

Commentary: How factor analysis sharpens investors’ evaluations of managers

Picking the right investment managers is a central challenge for any institutional investment program. The selection process can be complex, encompassing evaluating everything from track records to ...
Bloomberg L.P.

Finding Your “style”: Alpha Generation and Equity Factor Analysis in High Inflation Market

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. By submitting this information, I agree to the privacy policy and to learn more about ...
Bloomberg L.P.

Factor analysis shows how prolonged inflation will affect equity portfolios

Wondering how to reposition your U.S. equity portfolio to benefit from prolonged inflation? A factor analysis supports common assumptions about value outperforming in periods of higher-than-average ...
ascopubs.org

Multi-factor dynamic analysis of ctDNA and CTC to aid the diagnostic prognosis of patients with metastatic breast cancer (MBC).

Association of C-MYC, MYC target gene, and unfolded protein response (UPR) expression with clinical benefit from the oral aurora kinase A (AURKA) inhibitor, alisertib (A), in combination with ...
The New England Journal of Medicine

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

The goal of gene therapy for patients with hemophilia A is to safely impart long-term stable factor VIII expression that predictably ameliorates bleeding with the use of the lowest possible vector ...